Clinical Trial Update: A Clinical Study of Arfolitixorin in Patients With mCRC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating arfolitixorin in patients with metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Arfolitixorin (arfolitixorin)

Snippet

Sponsor: Isofol Medical AB | Conditions: Metastatic Colorectal Cancer (mCRC) | Phase 1, Phase 2 | Status: RECRUITING